Medable launched an "Agentic AI" product designed to help principal investigators (PIs) manage and assess electronic clinical outcome assessment (eCOA) data. The company says the agent is goal‑oriented, provides context‑aware decision support, and preserves human accountability with explicit roles, permissions, and human‑in‑the‑loop controls, according to Erika Motley, Medable’s director of product management. Medable positions the tool to reduce manual reconciliation burdens at research sites and accelerate PI review and sign‑off in regulated trials. The system is built to support regulatory review rather than passive monitoring, emphasizing investigator oversight while surfacing items needing clinical judgment.